NCT06871254 Spinal Cord Injury Neurorecovery Collaboration
| NCT ID | NCT06871254 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Melbourne |
| Condition | Spinal Cord Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-03-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
SCINC is an adaptive design Master protocol that seeks to determine if there is "sufficient promise" of beneficial effect of treatment combinations to enhance motor recovery in pre-specified strata of people with a spinal cord injury.
Eligibility Criteria
SCINC Inclusion Criteria: \- Person with SCI SCINC Exclusion Criteria: \- Proven contraindication to intervention RRULI: Appendix 1 (TIH + ET) study-specific inclusion criteria: * Adults \> 18 years of age * Able to independently ventilate * Chronic SCI (\>1 years post-injury or impairment onset) * Tetraplegia (C2-T1 level of injury) * Evidence of motor incomplete paralysis in the upper limb below the neurological level of injury * Have a documented management plan for their AD if it occurs. RRULI: Appendix 1 (TIH + ET) study-specific exclusion criteria: * Pregnancy * Medical instability, including current or recent (within the previous 6 weeks) infection or inflammation * Current or recent (within the previous 6 weeks) pressure ulcers or cutaneous lesions * Poorly controlled diabetes * An episode of AD in the previous 6 months that required medical intervention to resolve * Significant other neurological, psychiatric, pulmonary, cardiovascular, orthopaedic, or oncological conditions. * Currently taking part in another clinical trial * Upper limb contracture
Contact & Investigator
David Berlowitz, PhD
PRINCIPAL INVESTIGATOR
University of Melbourne
Frequently Asked Questions
Who can join the NCT06871254 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06871254 currently recruiting?
Yes, NCT06871254 is actively recruiting participants. Contact the research team at laura.stendell@unimelb.edu.au for enrollment information.
Where is the NCT06871254 trial being conducted?
This trial is being conducted at Heidelberg, Australia.
Who is sponsoring the NCT06871254 clinical trial?
NCT06871254 is sponsored by University of Melbourne. The principal investigator is David Berlowitz, PhD at University of Melbourne. The trial plans to enroll 24 participants.